YIPF6 Activators
YIPF6 activators include compounds that influence various aspects of vesicular trafficking, Golgi apparatus function, and intracellular transport. In the first paragraph, compounds like Brefeldin A, Monensin, and Nocodazole are highlighted for their ability to disrupt Golgi structure and microtubule stability, impacting YIPF6 activity in vesicle transport processes. Forskolin and PMA, by modulating cAMP levels and activating PKC, could also contribute to enhancing YIPF6 function in intracellular transport.
Attention is given to compounds like Chloroquine, Golgicide A, and Wiskostatin, which influence lysosomal function, Golgi apparatus dynamics, and actin cytoskeleton, respectively. Thapsigargin and Tunicamycin, known for inducing ER stress, could indirectly enhance YIPF6's activity in ER-Golgi trafficking. Additionally, Jasplakinolide and Cytochalasin D, by affecting actin dynamics, might also play a role in indirectly enhancing YIPF6's activity in vesicular trafficking and Golgi function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts Golgi structure, potentially enhancing YIPF6 activity by modulating Golgi apparatus dynamics and vesicular transport. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Ionophore that disrupts Golgi function, could enhance YIPF6 activity by affecting intracellular transport pathways. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Destabilizes microtubules, potentially influencing YIPF6 activity by altering vesicle transport processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Increases cAMP levels, potentially enhancing YIPF6 function through cAMP-mediated signaling pathways affecting vesicular trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates Protein Kinase C (PKC), potentially influencing YIPF6 activity in intracellular transport and Golgi function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Lysosomotropic agent, could enhance YIPF6 activity by modulating lysosomal function and associated trafficking pathways. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
Specifically targets Golgi brefeldin A resistance factor 1 (GBF1), potentially enhancing YIPF6 activity in Golgi apparatus function. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $48.00 $122.00 $432.00 $812.00 | 4 | |
Inhibits N-WASP, influencing actin dynamics, potentially affecting YIPF6 activity in vesicular transport. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
ER stress inducer, could indirectly enhance YIPF6 activity by affecting ER-Golgi trafficking pathways. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Induces ER stress, potentially enhancing YIPF6 function in response to altered protein processing and trafficking. | ||||||